• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Retrospective Analysis of Onychomycosis Risk Factors Using the 2003-2014 National Inpatient Sample.利用2003 - 2014年全国住院患者样本对甲癣危险因素进行回顾性分析。
Dermatol Pract Concept. 2024 Apr 1;14(2):e2024074. doi: 10.5826/dpc.1402a74.
2
Risk Factors and Treatment Trends for Onychomycosis: A Case-Control Study of Onychomycosis Patients in the All of Us Research Program.甲癣的危险因素及治疗趋势:“我们所有人”研究项目中甲癣患者的病例对照研究
J Fungi (Basel). 2023 Jun 29;9(7):712. doi: 10.3390/jof9070712.
3
Onychomycosis and Tinea Pedis in the Feet of Patients With Diabetes.糖尿病患者足部的甲癣和足癣
Int J Low Extrem Wounds. 2023 Jun;22(2):321-327. doi: 10.1177/15347346211009409. Epub 2021 Apr 23.
4
Prevalence and epidemiology of tinea pedis and toenail onychomycosis and antifungal susceptibility of the causative agents in patients with type 2 diabetes in Turkey.土耳其2型糖尿病患者足癣和趾甲甲真菌病的患病率、流行病学及致病原的抗真菌药敏性
Int J Dermatol. 2017 Jan;56(1):68-74. doi: 10.1111/ijd.13402. Epub 2016 Sep 26.
5
Comorbidity of tinea pedis and onychomycosis and evaluation of risk factors in Latino immigrant poultry processing and other manual laborers.足癣和甲癣的共病情况以及拉丁裔移民家禽加工工人和其他体力劳动者的危险因素评估
South Med J. 2014 Jun;107(6):374-9. doi: 10.14423/01.SMJ.0000450705.67259.26.
6
Subclinical onychomycosis is associated with tinea pedis.亚临床甲真菌病与足癣有关。
Br J Dermatol. 2009 Oct;161(4):746-9. doi: 10.1111/j.1365-2133.2009.09315.x. Epub 2009 Jun 24.
7
Onychomycosis and tinea pedis in athletes from the State of Rio Grande Do Sul (Brazil): a cross-sectional study.巴西南里奥格兰德州运动员的甲真菌病和足癣:一项横断面研究。
Mycopathologia. 2011 Mar;171(3):183-9. doi: 10.1007/s11046-010-9360-z. Epub 2010 Sep 28.
8
Onychomycosis in patients with psoriasis--a multicentre study.银屑病患者的甲真菌病——一项多中心研究。
Mycoses. 2012 Mar;55(2):143-7. doi: 10.1111/j.1439-0507.2011.02053.x. Epub 2011 Jul 20.
9
[Investigation of tinea pedis and toenail onychomycosis prevalence in patients with psoriasis].[银屑病患者足癣和趾甲甲真菌病患病率的调查]
Mikrobiyol Bul. 2009 Jul;43(3):439-47.
10
Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: a case-control study.足部慢性皮肤真菌病作为腿部急性细菌性蜂窝织炎的危险因素:一项病例对照研究。
Dermatology. 2004;209(4):301-7. doi: 10.1159/000080853.

本文引用的文献

1
High Frequency of Self-Diagnosis and Self-Treatment in a Nationally Representative Survey about Superficial Fungal Infections in Adults-United States, 2022.2022年美国一项关于成人浅表真菌感染的全国代表性调查中自我诊断和自我治疗的高频率
J Fungi (Basel). 2022 Dec 22;9(1):19. doi: 10.3390/jof9010019.
2
Onychomycosis in underrepresented groups: an all of us database analysis.未被充分研究群体中的甲癣:一项“我们所有人”数据库分析
Arch Dermatol Res. 2023 Apr;315(3):647-651. doi: 10.1007/s00403-022-02413-4. Epub 2022 Oct 19.
3
Poor Antifungal Coverage for Onychomycosis in a Cross-Sectional Analysis of Medicaid Formularies.在对医疗补助处方集的横断面分析中,甲真菌病的抗真菌药物覆盖率较低。
J Am Podiatr Med Assoc. 2022 Sep-Oct;112(5). doi: 10.7547/21-221.
4
Nail Changes in People Living with Human Immunodeficiency Virus: Observational and Cross-Sectional Study in a Third-Level Hospital.人类免疫缺陷病毒感染者的指甲变化:三级医院的观察性横断面研究
Skin Appendage Disord. 2022 Sep;8(5):368-375. doi: 10.1159/000524257. Epub 2022 Apr 22.
5
Prevalence of Onychomycosis in Diabetic Patients: A Case-Control Study Performed at University Hospital Policlinico in Catania.糖尿病患者甲癣的患病率:在卡塔尼亚大学综合医院进行的一项病例对照研究。
J Fungi (Basel). 2022 Aug 30;8(9):922. doi: 10.3390/jof8090922.
6
Updated Perspectives on the Diagnosis and Management of Onychomycosis.甲癣诊断与治疗的最新观点
Clin Cosmet Investig Dermatol. 2022 Sep 15;15:1933-1957. doi: 10.2147/CCID.S362635. eCollection 2022.
7
Race reporting and representation in onychomycosis clinical trials: A systematic review.甲真菌病临床试验中的种族报告和代表性:系统评价。
Mycoses. 2021 Aug;64(8):954-966. doi: 10.1111/myc.13262. Epub 2021 Mar 13.
8
Effect of onychomycosis and treatment on patient-reported quality-of-life outcomes: A systematic review.甲真菌病及其治疗对患者报告的生活质量结局的影响:系统评价。
J Am Acad Dermatol. 2021 Nov;85(5):1227-1239. doi: 10.1016/j.jaad.2020.05.143. Epub 2020 Jun 2.
9
Onychomycosis in Psoriatic Patients with Nail Disorders: Aetiological Agents and Immunosuppressive Therapy.银屑病患者甲病中的甲癣:病原体与免疫抑制治疗
Dermatol Res Pract. 2020 May 2;2020:7209518. doi: 10.1155/2020/7209518. eCollection 2020.
10
Epidemiology of Onychomycosis in an Academic Nail Unit in South Greece during a Three-Year Period.希腊南部一家学术性指甲科三年内甲癣的流行病学情况
Skin Appendage Disord. 2020 Mar;6(2):102-107. doi: 10.1159/000504812. Epub 2019 Dec 19.

利用2003 - 2014年全国住院患者样本对甲癣危险因素进行回顾性分析。

Retrospective Analysis of Onychomycosis Risk Factors Using the 2003-2014 National Inpatient Sample.

作者信息

Shah Vrusha K, Desai Amar D, Lipner Shari R

机构信息

University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Rutgers New Jersey Medical School, Newark, NJ, USA.

出版信息

Dermatol Pract Concept. 2024 Apr 1;14(2):e2024074. doi: 10.5826/dpc.1402a74.

DOI:10.5826/dpc.1402a74
PMID:38810060
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11135940/
Abstract

INTRODUCTION

Onychomycosis, a fungal nail infection, is associated with significant morbidity and negative impact on quality of life. Therefore, understanding associated risk factors may inform onychomycosis screening guidelines.

OBJECTIVES

This retrospective study investigated common demographic and comorbidity risk factors among hospitalized patients using the National Inpatient Sample.

METHODS

The 2003-2014 National Inpatient Sample (NIS) database was used to identify onychomycosis cases and age and sex matched controls in a 1:2 ratio. Chi-square tests and T-tests for independent samples were utilized to compare categorical and continuous patient factors. Demographic and comorbidity variables significant (P < 0.05) on univariate analysis were analyzed via a multivariate regression model with Bonferroni correction (P < 0.0029).

RESULTS

119,662 onychomycosis cases and 239,324 controls were identified. Compared to controls, onychomycosis patients frequently were White (69.0% versus 68.0%; P < 0.001), Black (17.9% versus 5.8%; P < 0.0001), and insured by Medicare or Medicaid (80.1% versus 71.1%; P < 0.0001). Patients had greater hospital stays (9.69 versus 5.39 days; P < 0.0001) and costs ($39,925 versus $36,720; P < 0.001) compared to controls. On multivariate analysis, onychomycosis was commonly associated with tinea pedis (odds ratio [OR]: 111.993; P < 0.0001), human immunodeficiency virus (OR: 4.372; P < 0.001), venous insufficiency (OR: 6.916; P < 0.0001), and psoriasis (OR: 3.668; P < 0.001).

CONCLUSIONS

Onychomycosis patients had longer hospital stays and greater costs compared to controls. Black patients were disproportionately represented among cases compared to controls. Onychomycosis was associated with tinea pedis, venous insufficiency, human immunodeficiency virus, psoriasis, obesity (body mass index [BMI] ≥ 30 kg/m), peripheral vascular disease, and diabetes with chronic complications, suggesting that inpatients with onychomycosis should be screened for these conditions.

摘要

引言

甲癣是一种指甲真菌感染,与严重的发病率以及对生活质量的负面影响相关。因此,了解相关风险因素可能为甲癣筛查指南提供依据。

目的

这项回顾性研究利用全国住院患者样本调查了住院患者中常见的人口统计学和合并症风险因素。

方法

使用2003 - 2014年全国住院患者样本(NIS)数据库,以1:2的比例识别甲癣病例以及年龄和性别匹配的对照。采用卡方检验和独立样本t检验来比较分类和连续的患者因素。单因素分析中具有显著意义(P < 0.05)的人口统计学和合并症变量通过带有Bonferroni校正(P < 0.0029)的多变量回归模型进行分析。

结果

共识别出119,662例甲癣病例和239,324例对照。与对照相比,甲癣患者多为白人(69.0%对68.0%;P < 0.001)、黑人(17.9%对5.8%;P < 0.0001),且由医疗保险或医疗补助承保(80.1%对71.1%;P < 0.0001)。与对照相比,患者的住院时间更长(9.69天对5.39天;P < 0.0001),费用更高(39,925美元对36,720美元;P < 0.001)。多变量分析显示,甲癣通常与足癣(优势比[OR]:111.993;P < 0.0001)、人类免疫缺陷病毒(OR:4.372;P < 0.001)、静脉功能不全(OR:6.916;P < 0.0001)和银屑病(OR:3.668;P < 0.001)相关。

结论

与对照相比,甲癣患者的住院时间更长,费用更高。与对照相比,黑人患者在病例中的占比过高。甲癣与足癣、静脉功能不全、人类免疫缺陷病毒、银屑病、肥胖(体重指数[BMI]≥30 kg/m²)、外周血管疾病以及伴有慢性并发症的糖尿病相关,这表明应对甲癣住院患者进行这些疾病的筛查。